58 related articles for article (PubMed ID: 15299414)
1. Crystallization studies of the human immunodeficiency virus (HIV-1) Tat protein and its trans-activation response element (TAR) RNA.
McKenna MC; Anderson D; Cascio D; Eisenberg D
Acta Crystallogr D Biol Crystallogr; 1994 Jul; 50(Pt 4):527-34. PubMed ID: 15299414
[TBL] [Abstract][Full Text] [Related]
2. Functional significance of the dinucleotide bulge in stem-loop1 and stem-loop2 of HIV-2 TAR RNA.
Rhim H; Rice AP
Virology; 1994 Jul; 202(1):202-11. PubMed ID: 8009832
[TBL] [Abstract][Full Text] [Related]
3. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
[TBL] [Abstract][Full Text] [Related]
4. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
5. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes.
Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ
Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463
[TBL] [Abstract][Full Text] [Related]
6. Using capillary electrophoresis to study methylation effect on RNA-peptide interaction.
Mucha P; Szyk A; Rekowski P; Agris PF
Acta Biochim Pol; 2003; 50(3):857-64. PubMed ID: 14515166
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
[TBL] [Abstract][Full Text] [Related]
8. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
Das AT; Harwig A; Vrolijk MM; Berkhout B
J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
[TBL] [Abstract][Full Text] [Related]
9. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.
Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M
Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus.
Athanassiou Z; Patora K; Dias RL; Moehle K; Robinson JA; Varani G
Biochemistry; 2007 Jan; 46(3):741-51. PubMed ID: 17223695
[TBL] [Abstract][Full Text] [Related]
11. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
Zhao H; Li J; Xi F; Jiang L
FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV.
Anand K; Schulte A; Vogel-Bachmayr K; Scheffzek K; Geyer M
Nat Struct Mol Biol; 2008 Dec; 15(12):1287-92. PubMed ID: 19029897
[TBL] [Abstract][Full Text] [Related]
13. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.
Lebars I; Richard T; Di Primo C; Toulmé JJ
Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acids that promote specific and rigid TAR RNA-tat protein complex formation.
Edwards TE; Robinson BH; Sigurdsson ST
Chem Biol; 2005 Mar; 12(3):329-37. PubMed ID: 15797217
[TBL] [Abstract][Full Text] [Related]
16. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.
Wang W; Guo Z; Chen Y; Liu T; Jiang L
Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893
[TBL] [Abstract][Full Text] [Related]
17. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
19. A comparative binding study of modified bovine immunodeficiency virus TAR RNA against its TAT peptide.
Tok JB; Bi L; Huang S
Bioorg Med Chem Lett; 2004 Dec; 14(24):6101-5. PubMed ID: 15546738
[TBL] [Abstract][Full Text] [Related]
20. [Study of transactivation effect on transcription by Tat-TAR-system of human immunodeficiency virus type 1 (HIV-1) in non-lymphoid cells HEK293 and Calu-1].
Mingaleeva RN; Chernov IP; Kopantsev EP; Stukacheva EA; Skaptsova NV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2009; (2):11-5. PubMed ID: 19517804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
